{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:16:18Z","timestamp":1785420978070,"version":"3.56.0"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cycloserine is recommended for inclusion in regimens for multidrug-resistant tuberculosis (MDR-TB). Its efficacy is time dependent and relies on the concentration remaining above the minimum inhibitory concentration (MIC); however, there is a concentration-dependent risk of neurotoxicity. Limited pharmacokinetic (PK) data are available in individuals of Indian origin, despite the high burden of MDR-TB in India. We enrolled adults and adolescents receiving cycloserine for MDR-TB at a tertiary hospital in Mumbai, India, in a prospective cohort. Total daily doses ranged from 500 to 750 mg, and participants underwent serial PK sampling on multiple visits starting 1 month after treatment initiation. PK data were analyzed using non-linear mixed-effect modeling. A total of 180 participants (117 females) were enrolled, with a median age of 27 years (interquartile range [IQR] 21\u201335), weight of 56.0 kg (IQR 46.0\u201365.9), and fat-free mass of 38.6 kg (IQR 32.3\u201347.1). Cycloserine PK was best described by a one-compartment model with first-order elimination and transit compartment absorption. Allometric scaling by fat-free mass provided the best adjusment for body size. Serum creatinine improved the model fit and allowed separate estimation of renal and non-renal clearances, whose typical values were 0.589 and 0.901 L\/h, respectively. Simulations showed median exposure of 308 mg\u00b7h\/L after 250 mg twice daily (BID), which is lower than reported in literature. Monte Carlo simulations suggested that doses of 500 or 750 mg BID are required to reach efficacy targets of \u226530% and \u226564% time within dose interval above MIC. The reasons behind the low exposure identified in this Indian population require further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/aac.00101-25","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T14:17:04Z","timestamp":1756822624000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of cycloserine dose regimens in an Indian cohort with multidrug-resistant tuberculosis: a population pharmacokinetic analysis"],"prefix":"10.1128","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9111-8052","authenticated-orcid":true,"given":"Juan Eduardo","family":"Resendiz-Galvan","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town","place":["Cape Town, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7015-0376","authenticated-orcid":false,"given":"Prerna R.","family":"Arora","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6fbp85","id-type":"ROR","asserted-by":"publisher"}],"name":"Research Laboratories, P. D. Hinduja National Hospital and Medical Research Centre","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan V.","family":"Lokhande","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6fbp85","id-type":"ROR","asserted-by":"publisher"}],"name":"Research Laboratories, P. D. Hinduja National Hospital and Medical Research Centre","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarir F.","family":"Udwadia","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6fbp85","id-type":"ROR","asserted-by":"publisher"}],"name":"Research Laboratories, P. D. Hinduja National Hospital and Medical Research Centre","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Rodrigues","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6fbp85","id-type":"ROR","asserted-by":"publisher"}],"name":"Research Laboratories, P. D. Hinduja National Hospital and Medical Research Centre","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Gupta","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00za53h95","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Infectious Diseases in India, Division of Infectious Diseases, Johns Hopkins University School of Medicine","place":["Baltimore, USA"]},{"id":[{"id":"https:\/\/ror.org\/00za53h95","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine","place":["Baltimore, USA"]},{"id":[{"id":"https:\/\/ror.org\/00za53h95","id-type":"ROR","asserted-by":"publisher"}],"name":"Bloomberg School of Public Health, Johns Hopkins University School of Medicine","place":["Baltimore, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1566-4622","authenticated-orcid":false,"given":"Jeffrey A.","family":"Tornheim","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00za53h95","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Infectious Diseases in India, Division of Infectious Diseases, Johns Hopkins University School of Medicine","place":["Baltimore, USA"]},{"id":[{"id":"https:\/\/ror.org\/00za53h95","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine","place":["Baltimore, USA"]},{"id":[{"id":"https:\/\/ror.org\/00za53h95","id-type":"ROR","asserted-by":"publisher"}],"name":"Bloomberg School of Public Health, Johns Hopkins University School of Medicine","place":["Baltimore, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7494-079X","authenticated-orcid":true,"given":"Paolo","family":"Denti","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town","place":["Cape Town, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2740-0819","authenticated-orcid":false,"given":"Tester F.","family":"Ashavaid","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a6fbp85","id-type":"ROR","asserted-by":"publisher"}],"name":"Research Laboratories, P. D. Hinduja National Hospital and Medical Research Centre","place":["Mumbai, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the The MDR-TB MUKT and Indo-South Africa Study Teams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lancelot","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai B.","family":"Mullerpattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Sunavala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigneshkumar M.","family":"Pater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad R.","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpa J.","family":"Dherai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heeral","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utkarsha","family":"Surve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woojae","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Vania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A.","family":"Martinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdaus","family":"Nabeemeeah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubbe","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_5_2_2","volume-title":"Global tuberculosis report 2023","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. 2023. Global tuberculosis report 2023"},{"key":"e_1_3_5_3_2","unstructured":"New Delhi: Ministry of Health & Family Welfare Government of India. 2021. Guidelines for programmatic management of TB preventive treatment in India 2021"},{"key":"e_1_3_5_4_2","volume-title":"WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. 2022 WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002202"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02511-2021"},{"key":"e_1_3_5_7_2","volume-title":"WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment","author":"World Health Organization","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment. Vol. 98."},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.03.015"},{"key":"e_1_3_5_9_2","unstructured":"Manufacturer Esteve Pharmaceuticals GmbH. 2023. Terizidone 250 mg capsules (Esteve pharmaceuticals GmbH*) TB346 WHOPAR part 4 suppliers submission of the SRA approved text"},{"key":"e_1_3_5_10_2","first-page":"72","article-title":"Antibacterial activity and blood and urine concentrations of cycloserine, a new antibiotic, following oral administration","volume":"1","author":"Welch H","year":"1955","unstructured":"WelchH, PutnamLE, RandallWA. 1955. Antibacterial activity and blood and urine concentrations of cycloserine, a new antibiotic, following oral administration. Antibiotic Med Clin Ther (New York) 1:72\u201379.","journal-title":"Antibiotic Med Clin Ther (New York)"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy624"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.03.001"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00055-19"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01700-22"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01381-20"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13975"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3726-8"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2020.477"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab615"},{"key":"e_1_3_5_20_2","unstructured":"Beal SL Sheiner LB Boeckmann AJ Bauer RJ. 2013. NONMEM users\u2019 guides (1989\u20132013). Ellicott City ICON Development Solutions"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-2607(98)00067-4"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/psp.2013.24"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-007-9066-0"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01113502"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1023\/a:1012299115260"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.48.113006.094708"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23574"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-017-9542-0"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-007-0333-y"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.01.024"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199936060-00004"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.11.891.34524"},{"key":"e_1_3_5_35_2","volume-title":"Technical Report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. 2018. Technical Report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis. World Health Organization, Geneva."},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.05.030"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S348428"},{"key":"e_1_3_5_38_2","volume-title":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance","author":"World Health Organization (WHO)","year":"2023","unstructured":"World Health Organization (WHO). 2023. Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance. Second edition"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01824-17"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy046"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00101-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00101-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:02:38Z","timestamp":1759323758000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00101-25"}},"subtitle":[],"editor":[{"given":"Sean","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1128\/aac.00101-25"],"URL":"https:\/\/doi.org\/10.1128\/aac.00101-25","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00101-25"}}